Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study

被引:0
|
作者
Sonoda, Dai [1 ]
Maruyama, Raito [1 ]
Kondo, Yasuto [1 ,2 ]
Naito, Masahito [1 ]
Mikubo, Masashi [1 ]
Shiomi, Kazu [1 ]
Satoh, Yukitoshi [1 ,2 ]
机构
[1] Kitasato Univ, Dept Thorac Surg, Sch Med, 1-15-1 Kitasato,Minami Ku, Sagamihara, Kanagawa 2520374, Japan
[2] Kitasato Univ, Dept Thorac Surg, Med Ctr, 6-100 Arai, Kitamoto, Saitama 36408501, Japan
关键词
Lung cancer; Older patients; Performance status; Prognostic factors; Recurrence; Treatment; ELDERLY-PATIENTS; LIFE EXPECTANCY; PHASE-III; OCTOGENARIANS;
D O I
10.1007/s00595-024-02938-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeSociety is aging, and the proportion of older patients with lung cancer is increasing. However, the treatment choices and prognoses for older patients with cancer recurrence remain unclear. We retrospectively investigated the treatment choices and prognoses of older patients with recurrence.MethodsWe conducted a retrospective review of 1100 patients who underwent complete resection for non-small cell lung cancer at Kitasato University Hospital between 2004 and 2017. Patients of >= 75 years of age were defined as older patients, and the prognosis and prognostic factors of these patients upon recurrence were examined.ResultsAmong the 290 patients who developed recurrence, 106 experienced recurrence at an older age. The factors associated with survival after recurrence included sex, time to recurrence, number of recurrences, performance status at recurrence, and active treatment. As the age at recurrence increased, the proportion of patients who did not receive active treatment increased, as did the proportion for whom the reason was the patient's and family's preferences.ConclusionsA considerable number of older patients who experience recurrence do not wish to receive active treatment. However, the prognosis can be improved by aggressive treatment for recurrence.
引用
收藏
页码:588 / 599
页数:12
相关论文
共 50 条
  • [41] Survival outcomes and prognostic factors in elderly patients with non-small cell lung cancer
    Park, S.
    Park, J. H.
    Kim, J. S.
    Choi, I. S.
    Kim, K. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S192 - S193
  • [42] Gemcitabine and docetaxel in non-small cell lung cancer (NSCLC) and study of prognostic factors
    Gamaz, M.
    Bouzid, K.
    Baba-Ahmed, R.
    Taright, S.
    Amrane, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 393 - 393
  • [43] Study of prognostic predictors for non-small cell lung cancer
    Fu, XL
    Zhu, XZ
    Shi, DR
    Xiu, LZ
    Wang, LJ
    Zhao, S
    Qian, H
    Lu, HF
    Xiang, YB
    Jiang, GL
    LUNG CANCER, 1999, 23 (02) : 143 - 152
  • [44] Estrogen receptor α and β are prognostic factors in non-small cell lung cancer
    Kawai, H
    Ishii, A
    Washiya, K
    Konno, T
    Kon, H
    Yamaya, C
    Ono, I
    Minamiya, Y
    Ogawa, J
    CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5084 - 5089
  • [45] Prognostic Factors for Brain Metastasis in Non-Small Cell Lung Cancer
    Duma, Narjust
    Sanchez, Laysa
    Miranda, Claudia
    Glisch, Chad
    Abu-Ihweij, Khaleb
    Zhang, Shijia
    Osorio, Carlos
    Listo, Matthew
    Harper, Harry D.
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [46] Molecular prognostic factors in resectable non-small cell lung cancer
    Vielh, P
    Spano, JP
    Grenier, J
    Le Chevalier, I
    Soria, JC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) : 193 - 197
  • [47] PROGNOSTIC FACTORS FOR ADVANCED NON-SMALL CELL LUNG CANCER IN JAPANESE
    Mizutani, Tomonori
    Takeda, Yuichiro
    Naka, Go
    Horio, Yuko
    Fujita, Yu
    Sugiyama, Eri
    Yagishita, Shigehiro
    Ishi, Satoshi
    Hirano, Satoru
    Kobayashi, Nobuyuki
    Kudo, Kouichiro
    ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
  • [48] Prognostic factors in stage I non-small cell lung cancer
    Thomas, P
    Barlesi, F
    Doddoli, C
    Pietri, P
    Astoul, P
    Giudicelli, R
    Fuentes, P
    New Advances in Thoracic Oncology: From Scientific Evidence to Optimal Management, 2005, 350 : 37 - 48
  • [49] Prognostic factors in locally advanced non-small cell lung cancer
    Hadidene, Y.
    Kamoun, H.
    Rejeb, H.
    Greb, D.
    Akrout, I.
    Fkih, L.
    Smadhi, H.
    Megdiche, M. L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] New prognostic factors in resectable non-small cell lung cancer
    Smit, EF
    Groen, HJM
    Splinter, TAW
    Ebels, T
    Postmus, PE
    THORAX, 1996, 51 (06) : 638 - 646